Skip to content

To study the effect of Chandrashoor ladu( dietary supplement) on minimising menstrual period related pain.

An exploratory clinical trial to evaluate role of Chandrashoor(Lepidium sativum Linn.) Ladu in Kashtartava(Primary Dysmenorrhea) as Shoolaghna.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025058
Enrollment
40
Registered
2020-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Use of Chandrashoor(Lepidium sativum Linn.)Ladu Ingredients- Chandrashoor,Jaggery,Coconut and Ghritam(ghee).: In this study, Chandrashoor Ladu 30gm/day will be given to the patients of

Sponsors

CARC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with chief complaint of painful menses and associated symptoms at least for three cycles. 2.Patients with pain for at least for first 2 days of the cycle. 3.Nulliparous females. 4.Age group-15 to 28 years irrespective of caste and religion.

Exclusion criteria

Exclusion criteria: 1.Patients with chronic illness for example, DM and any systemic disorder. 2.Any diagnosed uterine pathology (Menorrhagia,Fibroid,Adenomycosis, Endometriosis). 3.Patients undergoing hormonal treatment for Dysmenorrhea. 4.Patients with Pitta Prakruti. 5.Patients with heavy menstrual bleeding.

Design outcomes

Primary

MeasureTime frame
To evaluate role of chandrashoor Ladu in minimising spasmodic pain caused by kashtartava(primary dysmenorrhea).Timepoint: 2 months

Secondary

MeasureTime frame
To evaluate role of Chandrashoor Ladu in minimising Kashtartava(primary dysmenorrhea) associated symptoms.Timepoint: 2 months

Countries

India

Contacts

Public ContactDr Supriya Sanap

PDEAs College of Ayurved and Research Centre

arfirke@gmail.com8888845674

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026